Impact BioMedical Inc. (IBO) stock
IBONYSEPharmaceutical PreparationsFiscal year ends December 31
$3.06+0.38 (+14.18%)
Close on Oct 19, 2026Market cap $329.93MP/E –Yield –
Impact BioMedical pe ratio
The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.
Impact BioMedical's pe ratio was 33.0× on Oct 19, 2026.
PE Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Oct 19, 2026 | 33.0× | +31.7 |
| 2025 | Jan 31, 2025 | 1.3× | +0.2 |
| 2024 | Dec 31, 2024 | 1.1× | – |
See a number that looks wrong?